Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander V Uihlein

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Anabolic therapies for osteoporosisAlexander V Uihlein, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|March 21, 2014
FSH suppression does not affect bone turnover in eugonadal menAlexander V Uihlein, Joel S Finkelstein, Hang Lee, et al.
Journal of Neurochemistry|April 5, 2003
1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3Tiesong Shang, Alexander V Uihlein, Jennifer Van Asten, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2016
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled TrialBenjamin Z Leder, Joy N Tsai, Robert M Neer, et al.
Lancet (London, England)|July 7, 2015
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trialBenjamin Z Leder, Joy N Tsai, Alexander V Uihlein, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trialBenjamin Z Leder, Joy N Tsai, Alexander V Uihlein, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 22, 2014
Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT StudyJoy N Tsai, Alexander V Uihlein, Sherri-Ann M Burnett-Bowie, et al.
Lancet (London, England)|May 21, 2013
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trialJoy N Tsai, Alexander V Uihlein, Hang Lee, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Anabolic therapies for osteoporosisAlexander V Uihlein, Benjamin Z Leder
The Journal of Clinical Endocrinology and Metabolism|March 21, 2014
FSH suppression does not affect bone turnover in eugonadal menAlexander V Uihlein, Joel S Finkelstein, Hang Lee, et al.
Journal of Neurochemistry|April 5, 2003
1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3Tiesong Shang, Alexander V Uihlein, Jennifer Van Asten, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2016
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled TrialBenjamin Z Leder, Joy N Tsai, Robert M Neer, et al.
Lancet (London, England)|July 7, 2015
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trialBenjamin Z Leder, Joy N Tsai, Alexander V Uihlein, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trialBenjamin Z Leder, Joy N Tsai, Alexander V Uihlein, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 22, 2014
Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT StudyJoy N Tsai, Alexander V Uihlein, Sherri-Ann M Burnett-Bowie, et al.
Lancet (London, England)|May 21, 2013
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trialJoy N Tsai, Alexander V Uihlein, Hang Lee, et al.
Pageof 1